One of the key factors driving the market growth is the rise in the occurrence of chronic cardiovascular diseases such as heart failure and coronary artery disease: Valuates Reports
As part of this strategic partnership, LTI with its digital, technical and life sciences domain capabilities, will help accelerate joint go-to-market pursuits and faster deployment for Clinpal Adopters
The investment will increase SpeeDx internal capacity to scale up manufacturing
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
The FDA also approved Repatha as an adjunct to other LDL-C lowering therapies for the treatment of homozygous familial hypercholesterolemia (HoFH) for younger pediatric patients
The company plans to launch its exclusive e-pharmacy and telemedicine services in India by December 2021
It paves way for the launch of Selumetinib 10 mg & 25 mg capsule in India, subject to the receipt of related statutory approvals and licenses
CuraTeQ Biologics is on track for filing a second oncology biosimilar
These modules will act as a guide to doctors and health care workers to deal with post-Covid-19 issues
The bank will provide a complete range of financing options including hospitals, labs, diagnostic centres and equipment manufacturers
Subscribe To Our Newsletter & Stay Updated
